Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
16
NCT04679493
Study to Assess Safety, Tolerability and Pharmacokinetics of XC7 (Which is Planned Use in the Treatment of COVID-19) in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 17, 2020
Completion: Apr 9, 2021